Cashu Finance
  • Terminal
  • Stocks
  • Spotlight
  • Research
Log inSign Up
  1. Stocks
  2. Healthcare
  3. NASDAQ
  4. AIDX

Market Cap: $6.86M

2I

20/20 Biolabs Inc.

AIDX
NASDAQUSD
Purchase AIDX
OverviewNewsAnalyst ReportsFinancialsPolitician TradesInsider TradesExecutivePatentsEarnings Surprise
Cashu Finance

By Cashu Finance. Providing market news, analysis, and research for investors worldwide.

Company

StocksAboutAdvertisersBrokersContact

Legal

Terms of ServicePrivacy Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Finance is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Finance is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Finance and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Executive

Jonathan Cohen

Founder, CEO, President & Director

Compensation
$325,499
Alan Bergman

Chief Financial Officer

Compensation
Compensation not disclosed
Jiming Zhou

Chief Operating Officer

Compensation
$225,647
David Lees

Director of Sales

Compensation
Compensation not disclosed
Marc Gordon

Controller

Compensation
Compensation not disclosed
Michael S. Lebowitz

Chief Scientific Officer

Compensation
$89,600
Ronald R. Baker

Chief Business Officer

Compensation
Compensation not disclosed